HeartSciences Aktie - HSCS

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

3,2277

Gebot

3,22

Fragen

3,64

Volumen

6.234

3,1399 Tagesbereich 3,30

2,36 52-Wochen-Bereich 18,50

Marktkapitalisierung

3,164M

Handelsende

3,30

Handelsbeginn

3,30

Letzte Trade

3.47

Letzter Handelszeitpunkt

Finanzvolumen

US$ 19.971

VWAP

3,2036

Durchschnittliches Volumen (3 Mio.)

35.017

Ausgegebene Aktien

980.321

Dividendenrendite

Kurs-Gewinn-Verhältnis

-0,48

Gewinn pro Aktie (EPS)

-6,74

Erlöse

19k

Nettogewinn

-6,61M

Heart Test Laboratories Inc is a medical technology company focused on applying innovative AI-based technology to an ECG to expand and improve an ECG's clinical usefulness. The objective of the company is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-o... Heart Test Laboratories Inc is a medical technology company focused on applying innovative AI-based technology to an ECG to expand and improve an ECG's clinical usefulness. The objective of the company is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. Mehr anzeigen

Sektor

Ortho,prosth,surg Appl,suply

Branche

Ortho,prosth,surg Appl,suply

Website

www.heartsciences.com

Hauptsitz

Southlake, Texas, USA

Gegründet

HeartSciences Inc is listed in the Ortho,prosth,surg Appl,suply sector of the NASDAQ with ticker HSCS. The last closing price for HeartSciences was US$3,30. Over the last year, HeartSciences shares have traded in a share price range of US$ 2,36 to US$ 18,50.

HeartSciences currently has 980.321 shares in issue. The market capitalisation of HeartSciences is US$3,24 million. HeartSciences has a price to earnings ratio (PE ratio) of -0.48.

HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results

Southlake, TX, Dec. 16, 2024 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company...

HeartSciences’ AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement

Southlake, TX, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence...

HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit

Southlake, TX, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence...

HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results

Southlake, TX, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence...

HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission

Southlake, TX, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence...

HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results

Southlake, TX, July 29, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence...

Innovation Value Institute Analysis Demonstrates HeartSciences’ MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency

Southlake, TX, July 26, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence...

HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare

Southlake, TX, July 25, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence...

HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction

Southlake, Texas, July 11, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence...

HeartSciences Regains Compliance with Nasdaq Listing Requirements

Southlake, TX, June 04, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	-0.2223	-6.44347826087	3.45	3.4792	3.18	14589	3.3006624	CS
4	-0.4636	-12.559260965	3.6913	3.88	3.1	14814	3.4083617	CS
12	0.4577	16.523465704	2.77	4.6902	2.5164	35017	3.55400012	CS
26	-0.5823	-15.2834645669	3.81	5.2989	2.36	197682	4.02299687	CS
52	-10.1723	-75.9126865672	13.4	18.5	2.36	854272	10.55710714	CS
156	-371.7723	-99.13928	375	600	2.36	1689734	77.2353799	CS
260	-371.7723	-99.13928	375	600	2.36	1689734	77.2353799	CS

HSCS - Frequently Asked Questions (FAQ)

What is the current HeartSciences share price?

The current share price of HeartSciences is US$ 3,2277

How many HeartSciences shares are in issue?

HeartSciences has 980.321 shares in issue

What is the market cap of HeartSciences?

The market capitalisation of HeartSciences is USD 3,24M

What is the 1 year trading range for HeartSciences share price?

HeartSciences has traded in the range of US$ 2,36 to US$ 18,50 during the past year

What is the PE ratio of HeartSciences?

The price to earnings ratio of HeartSciences is -0,48

What is the cash to sales ratio of HeartSciences?

The cash to sales ratio of HeartSciences is 166,49

What is the reporting currency for HeartSciences?

HeartSciences reports financial results in USD

What is the latest annual turnover for HeartSciences?

The latest annual turnover of HeartSciences is USD 19k

What is the latest annual profit for HeartSciences?

The latest annual profit of HeartSciences is USD -6,61M

What is the registered address of HeartSciences?

The registered address for HeartSciences is 550 RESERVE ST, SUITE 360, SOUTHLAKE, TEXAS, 76092

What is the HeartSciences website address?

The website address for HeartSciences is www.heartsciences.com

Which industry sector does HeartSciences operate in?

HeartSciences operates in the ORTHO,PROSTH,SURG APPL,SUPLY sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
TCTMTCTM Kids IT Education Inc	US$ 0,764 (321,87%)	729,72M
REBNReborn Coffee Inc	US$ 3,31 (63,05%)	55,54M
FCUVFocus Universal Inc	US$ 5,87 (56,62%)	1,73M
SOPASociety Pass Inc	US$ 1,54 (56,50%)	13,82M
CYCNCyclerion Therapeutics Inc	US$ 3,92 (54,33%)	82,39M
ENVBEnveric Biosciences Inc	US$ 2,0899 (-46,41%)	1,57M
NIVFNewGenIvf Group Ltd	US$ 0,1489 (-42,51%)	14,8M
GLSTGlobal Star Acquisition Inc	US$ 8,83 (-39,10%)	23,89k
PRPHProPhase Labs Inc	US$ 0,2633 (-38,02%)	872,46k
SPGCSacks Parente Golf Inc	US$ 0,5601 (-37,86%)	7,27M
TCTMTCTM Kids IT Education Inc	US$ 0,764 (321,87%)	729,72M
NVDANVIDIA Corporation	US$ 120,07 (-3,67%)	388,54M
RIMEAlgorhythm Holdings Inc	US$ 0,02565 (5,12%)	338,75M
BHATBlue Hat Interactive Entertainment Technology	US$ 0,0355 (-11,25%)	236,29M
CLEUChina Liberal Education Holdings Ltd	US$ 0,1938 (30,77%)	234,8M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

HeartSciences Inc (HSCS) Börsenkurse

HeartSciences Inc (HSCS)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Über HeartSciences Inc

HSCS Neueste Nachrichten

HSCS - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen